Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release Mar 24 2021
Published Mar 24 2021
5 min read

Press Release Mar 24 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 24, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGTexclusivity".

View Attachment